Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Yale University
Yale University
University of Arkansas
Shanghai Zerun Biotechnology Co.,Ltd
University of Witwatersrand, South Africa
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
British Columbia Cancer Agency
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
M.D. Anderson Cancer Center
Albert Einstein College of Medicine
Barretos Cancer Hospital
Genexine, Inc.
Hoffmann-La Roche
Alliance for Clinical Trials in Oncology
BioLeaders Corporation
Xiamen University
University of Alabama at Birmingham
Washington University School of Medicine
Barretos Cancer Hospital
Mithra Pharmaceuticals
National Cancer Institute (NCI)
Medical University of Vienna
Tigris Pharmaceuticals
Tigris Pharmaceuticals